Jump to content
  • articles
    9,899
  • comments
    84
  • views
    12,585,780

Contributors to this article

About this News

Articles in the news

Over 1,000 more GPs to be recruited this year

The Department of Health and Social Care has announced that it will will recruit more than 1,000 newly qualified GPs thanks to action to remove red tape.

Currently, under a scheme known as the Additional Roles Reimbursement Scheme, primary care networks (PCNs) can claim reimbursement for the salaries (and some on costs) of 17 new roles within the multidisciplinary team – meaning more specialists are available to treat patients.

They are selected to meet the needs of the local population, but are currently prevented from using this to recruit additional GPs. The changes announced today means that newly qualified GPs  can quickly be recruited into the NHS through this scheme in 2024-2025.

Read full story

Source: Department of Health and Social Care, 1 August 2024

Read more

Over £800 million to boost innovation, growth and improve patient safety

Patients up and down the country are set to benefit from innovative new treatments and improved delivery of health and care services following significant funding to support ground-breaking experimental medicine research and advance the UK’s response to patient safety challenges.

  • £790 million to support breakthroughs in new treatments, diagnostics and medical technology to improve patients’ lives and bolster the economy.
  • £25 million for research on patient safety to improve the safe delivery of health and care and better address health challenges, such as cancer treatment and reducing medication error.
  • Exceeds funding commitments to boost research across all areas of the country, levelling up innovation and addressing health inequalities.

The government has announced that over £800 million of funding, to be allocated by the National Institute for Health and Care Research (NIHR), will go to support specialist research facilities bringing together scientists to create an environment where experimental medicine and patient safety research can thrive.

This boost to the country’s research infrastructure will see further investment in scientific expertise which supports access to innovative technology and novel research projects. As well as this, it will improve regional economic growth through employment opportunities, giving private sector organisations confidence to continue to invest in research across the country.

Read full story

Source: GOV.UK, 14 October 2022

Read more
 

Ovarian cancer: Setback as major screening trial fails to save lives

A major trial to detect one of the most elusive and deadly cancers - ovarian - has failed to save lives, after two decades of work.

The researchers, at University College London, said the results were a disappointment - and thanked the 200,000 people who participated.

The trial had looked promising, with annual blood tests detecting cases of ovarian cancer earlier. But routine screening for the cancer is now a distant prospect.

Ovarian cancer is tricky to diagnose because the symptoms are easily mistaken for less serious health problems.

"Some women are diagnosed so late they are too sick to start treatment," the trial's lead investigator, Prof Usha Menon, said.

The UK Collaborative Trial of Ovarian Cancer Screening - the largest in the world - tracked levels of CA125, a chemical released by ovarian tumours, in the blood and sent participants in whom they were rising for an ultrasound scan.

Unfortunately the final results, published in the Lancet medical journal, showed the screening had failed to save lives.

Read full story

Source: BBC News, 12 May 2021

Read more

Ovarian cancer: 1 in 4 patients ‘see GP three times before referral for tests’

More than a quarter of women with ovarian cancer saw their GP three or more times before getting a referral for tests, according to a new study.

Researchers also found that almost a third had waited for longer than three months after first going to see their GP before being given the right diagnosis.

If doctors are able to diagnose ovarian cancer at the earliest stage, nine out of 10 women will go on to live for five years or longer, but only around one in 10 survive if it is not caught until it has progressed to stage 4, the most advanced stage.

The report, by Target Ovarian Cancer, also revealed that 14 per cent of women polled said they were not given their diagnosis in private, meaning others could listen in on the exchange.

“I was told of my stage 4 diagnosis behind the curtain on a busy respiratory ward. The rest of the ward heard the conversation,” one woman said.

Meanwhile, GPs and ovarian cancer patients told researchers that the support available for the disease is insufficient – with almost half of the women polled not having been asked by a doctor, nurse or other individual providing treatment about how the cancer diagnosis was affecting their mental health.

This is despite the fact that 60% of the women diagnosed with ovarian cancer said their mental health had been harmed by the disease.

Read full story

Source: The Independent. 18 October 2022

Read more

Ovarian cancer symptoms are being ignored, UK charity warns

GPs and women are still ignoring key symptoms of ovarian cancer despite better awareness of the disease, a charity has warned, prompting fears that yet more patients will be diagnosed late and “die needlessly”.

Symptoms include frequently having a swollen tummy or feeling bloated; pain or tenderness in the tummy or the pelvis; having no appetite or feeling full quickly after eating, and an urgent need to pee or needing to pee more often, according to the NHS.

However, Target Ovarian Cancer is concerned that despite successful campaigns to boost awareness of the disease, many are still failing to act on the vital signs. “Key symptoms are being ignored – both by those experiencing them and their GPs,” a spokesperson said.

A poll of 1,000 women for the charity found 79% did not know that bloating was a symptom, while 68% were unaware abdominal pain was a sign, and 97% did not know feeling full was another. Most women (99%) did not know that needing to pee more urgently was also a sign, while evidence suggests women can often be told by their GP that their symptoms are more a symptom of irritable bowel syndrome (IBS), Target Ovarian Cancer said.

Ovarian cancer kills about a third of women with the disease in the first year after diagnosis, and is often diagnosed in the late stages. There are about 7,500 new ovarian cancer cases in the UK every year.

“These figures are incredibly disappointing,” said Annwen Jones, the chief executive of Target Ovarian Cancer. “We know we’ve shifted the dial in the past 10 years through the dedication of thousands of Target Ovarian Cancer’s campaigners, but it is not enough. Knowing the symptoms is crucial for everyone.

“We need to make sustained and large-scale government-backed symptoms campaigns a reality. Progress is possible. If we do this, fewer people will be diagnosed late, fewer will need invasive treatment, and, ultimately, fewer will die needlessly from ovarian cancer.”

Read full story

Source: The Guardian, 22 February 2022

Read more

Ovarian cancer blood test can detect disease early, study suggests

Scientists have developed a simple blood test to spot ovarian cancer early that could “significantly improve” outcomes for women with the disease.

More than 300,000 women, mostly over the age of 50, are diagnosed worldwide each year, according to the World Cancer Research Fund. Ovarian cancer is often diagnosed late, which makes treating the condition more difficult.

The test trialled by UK and US researchers looks for two different types of blood markers in those showing symptoms of the disease, which include pelvic pain and a bloated tummy. It then uses machine learning to recognise patterns that would be difficult for humans to detect.

Currently, the disease is usually diagnosed using a mix of scans and biopsies, such as an ultrasound scan, a CT scan, a needle biopsy, a laparoscopy or surgery to remove tissue or possibly the ovaries.

Read full story

Source: Guardian, Tuesday 26 August 2025

 
Read more

Outstanding trust handed warning notice

An ‘outstanding’ rated acute trust has been served with a warning notice by the Care Quality Commission (CQC) and told to make ‘significant and immediate improvements’ to its mental health and learning disabilities services.

The CQC said staff at Newcastle upon Tyne Hospitals Foundation Trust had not always carried out mental capacity assessments when people presented with mental health needs. And this included when decisions were made to restrain patients in the emergency department.

A CQC warning notice, published alongside a report of an inspection between 30 November and 1 December last year, says the trust must make “significant and immediate improvements in the quality of care being provided” to people with mental health issues, learning disabilities or autism.

The warning notice also says the trust must ensure people with a learning disability and autistic people “receive care which meets the full range of their needs”. The trust’s records “did not show evidence that staff had considered patients’ additional needs,” the regulator said.

Read full story (paywalled)

Source: HSJ, 24 February 2023

Read more

Outstanding air ambulance team 'go the extra mile'

An air ambulance service has been praised by inspectors for providing an "outstanding level of care".

The Care Quality Commission (CQC) carried out checks on the Essex & Herts Air Ambulance Trust (EHAAT) in August and September.

The report said patients felt "truly respected and valued as individuals" and described teamwork as "exemplary".

Ben Myer, EHAAT head of clinical delivery, said "everyone worked so hard to make the desired result a reality".

The service provides emergency care and transport in Essex and Hertfordshire, and surrounding areas when needed.

As well as being rated outstanding overall, the charity was also rated outstanding for being safe, effective, caring, responsive to people's needs - and being well-led.

Jane Gurney, EHAAT chief executive, thanked the local community for supporting the service, and issued a personal thank you to "each team member across the charity, whatever their role, all of whom work so hard every day to uphold these high standards".

Read full story

Source: BBC News, 12 October 2022

Read more
 

Outrage at chronic fatigue syndrome advice update pause

With just hours left to go, a health watchdog has paused a final update to ME treatment guidance due to disagreement on some of it's contents. Charities have expressed their anger over this decision as NICE says it needs more discussions with patient groups and professionals so that the advice is supported.

Although it is not yet clear when the guidance will be published, the advice on CBT (cognitive behavioural therapy) has been changed as it was only helping with anxiety around the condition rather than the illness itself, with NICE acknowledging the controversy over the best treatment has served only to alienate many people with the condition.

"We were extremely concerned that the final guidelines proposed by NICE may not have taken into consideration the extensive comments we made to the draft version, particularly in relation to treatments we know to have significantly benefited many patients." Andrew Goddard, president of the Royal College of Physicians, has said. 

Read full story.

Source: BBC News, 17 August 2021

Read more
 

Outdated hospital oxygen systems a ‘risk to patients’, review warns

A new review by a Healthcare Safety Investigation Branch (HSIB) found outdated systems used to provide oxygen around hospitals struggled to cope with demand, particularly during the winter months during the Covid surge. 

HSIB was created to investigate safety issues in England, and have said the problems with oxygen was not isolated to just one hospital. 

Read full story.

Source: BBC News, 24 June 2021

Read more

Outcry over 123 rejected ‘new hospital’ bids

Multiple trusts have expressed disappointment at being overlooked in the government’s latest announcement on the ‘40 new hospitals’ programme.

In 2021, ministers expanded the new hospitals programme by inviting bids for another eight projects to be funded nationally. However, last week they confirmed that just five new bids – all acute hospitals with unsafe roof plank structures – had been accepted.

Multiple mental health trusts have also expressed frustration, after just one new mental health scheme has been included in the list of 40 “new” hospitals, although the government is counting three which were already in progress outside the programme.

Joe Rafferty, chief executive of Mersey Care, has compared a lack of investment into mental health estate to “institutionalised discrimination”. Bradford District Care said it was “very disappointing” to find out its bid to replace “wholly unsuitable” wards designed in the 1950s had not been accepted, adding: “Still no parity for mental health in the total NHP funding allocation so far.”

Read full story (paywalled)

Source: HSJ, 31 May 2023

Read more

Outcome of the expert review of the safety of isotretinoin

Following an in-depth expert safety review of the acne drug isotretinoin (commonly known by brand names Roaccutane and Reticutan), the Commission on Human Medicines (CHM) has agreed to a number of recommendations to strengthen the safe use of the treatment.

Isotretinoin is used to treat severe forms of acne, especially if there is a risk of permanent scarring. This medicine is an extremely effective last-line treatment for severe acne. However, patients and members of the public have raised concerns about suspected side effects associated with isotretinoin, including psychiatric (mental health) and sexual side effects that sometimes continue after treatment with isotretinoin has been stopped.

Key recommendations include:

  • Better information for patients and their families about the risks of isotretinoin so that they can make an informed decision before using this medicine.
  • Consistent monitoring of a patient’s psychiatric and sexual health so that any problems are spotted earlier and there are defined routes for patients to receive help.
  • Tighter controls on first prescribing isotretinoin to young people (aged 12 to 18) so that it is only started when doctors agree the acne is severe enough to justify it and that other standard treatments have been sufficiently tried and haven’t worked.

Patient Safety Commissioner, Henrietta Hughes tweeted last night: "I welcome the new recommendations from @MHRAgovuk to strengthen the safe use of isotretinoin. Courageous patients and families have shared their experience with the review. It’s only by listening and acting that we can meet patients’ needs."

Read MHRA press release, 26 April 2023

Read more

Our newborn died due to NHS errors — we were treated with contempt

For the past three years, Ryan Parker and Emmie Studencki should have been watching their baby son Quinn grow up. He would be almost four now, preparing to start school in the autumn and playing with his sisters Ajla and Hazel.

Instead, the couple from Barrowby, Lincolnshire, have faced an “inhumane” battle with the NHS and its regulator to get justice for Quinn. He died in July 2021 from care so bad it has now been judged criminal.

Quinn died after being starved of oxygen because his mother suffered a placental abruption. In the preceding week, staff failed to give his parents crucial safety information and signs to look out for. Medical notes include reference to a suspicion of a placental abruption but they were not told this was the working diagnosis when his mother was sent home.

Read the full story

Source: The Times, 16 February 2025

Read more

Our mother wasn’t taken seriously — and died of cancer at 44

A mother of five died of endometrial cancer hours after being admitted to A&E following preventable delays in her diagnosis.

An inquest was told that a private clinic identified the cancer by ultrasound but the report was never sent to her GP.

Kerri Mothersole, 44, from Swale in Kent, had a complex medical history including decades of depression and chronic back pain.

Her 21-year-old son, Jordan Dighton, said: “My mum should have been taken more seriously—if she were, maybe she’d still be alive.”

In May 2020 Mothersole presented with symptoms of early menopause. Blood tests showed that she had low iron levels and her symptoms persisted. In March 2021 she told her GP at Green Porch Medical Centre that she had had vaginal bleeding for six weeks.

She could not attend her ultrasound appointments because she was the family’s only driver, and was removed from the waiting list despite rescheduling two appointments.

In June of that year her GP referred her for an NHS scan at HEM Clinical Ultrasound Service in Sittingbourne. A radiographer, who was new to the private clinic, found a suspected ovarian mass. However, the clinical lead deemed the scan results inaccurate so they were never returned to the GP. Instead Mothersole was asked to attend a second pelvic and abdominal scan. She was losing weight and in persistent pain. Despite her symptoms being gynaecological, she underwent what turned out to be a clear colonoscopy. According to the coroner, had the first scan report been seen this would have led to an urgent referral to gynaecology.

Mothersole was eventually admitted to A&E, where she remained under the care of oncology until she was discharged home to the care of hospice nurses.

Dighton told The Times, “The system was so siloed and her case was passed around from department to department. It’s only after her death that we’ve started to make sense of what pathways she should have been on.”

Read full story (paywalled)

Read the Prevention of Future Deaths Report for Kerri Mothersole

Source: The Times, 15 May 2024

Read more

Our job is to keep people out of A&E

As the pressures of winter and the Covid treatment backlog grow, the NHS is struggling. In Manchester, one organisation is pioneering a new way to care for people that tries to reduce the burden on the health service.

It's the first call-out of the day for nurse Manju and pharmacist Kara in north Manchester. They are on their way to see Steven, who has been diagnosed with Parkinson's disease and had a fall the previous night.

This might have led to a call-out for an ambulance crew and a visit to A&E. But instead the Manchester Local Care Organisation (LCO) stepped in.

Once at Steven's house, Manju makes sure he hasn't been harmed by his fall, while Kara checks his medication.

Manju notes that Steven's tablets could have contributed to his fall.

Manju asks Steven how he copes going up and down the stairs.

"I'm OK, just about," he says. But when he has a go at coming down the stairs, Manju spots he could use an extra grab rail and says she will sort one out.

This intervention by the team has not only avoided Steven ending up in A&E, but also ensures he can continue to live independently in his own home.

That's a key part of the LCO mission, according to Lana McEwan, one of the team leaders in north Manchester.

"We would consider ourselves to be an admission-avoidance service, so we're trying to prevent ambulances being called in the first instance.

"When an ambulance has been called, we're taking referrals directly from the ambulance service and responding within a one or two-hour response depending on need, and that's an alternative to A&E."

Local neighbourhood teams are made up of nurses, social workers, pharmacists and doctors, all working together to keep people out of hospital.

Read full story

Source: BBC News, 9 December 2022

Read more

Our daughter died from meningitis after starting uni - a jab would have saved her

A popular and sporty teenager who made a "big impression" at her new university died within weeks of starting, after contracting meningitis.

Meg Draper was 18 and had joined swimming and netball teams, but died in October from meningococcal type B meningitis, external (MenB) while studying physiotherapy in Bournemouth.

Her parents, from Pontypool, Torfaen, and the National Union of Students UK, external are now calling for a vaccine, or booster, to be made available to young adults on the NHS.

Read full story

Source: BBC News, 1 December 2025

Read more

Our children waited too long for the same diagnosis as Jesy Nelson's twins

Parents of babies born with a life-limiting, rare condition say their diagnoses came months too late, and after they had initially raised the alarm about their symptoms.

Dani-Rae Brown was diagnosed with Spinal Muscular Atrophy (SMA) seven months after her first symptom and now has to use a wheelchair, while Lucian Neale was diagnosed at six weeks old despite showing symptoms in his mother's womb.

SMA is a progressive muscle-wasting disease that can cause death within two years if untreated.

Read full story

Source: BBC News, 5 January 2026

Read more

Osteoporosis patients ‘abandoned’ after being diagnosed by text, damning inquiry reveals

The NHS is failing osteoporosis patients, diagnosing them via text message only to then "forget" them, a damning parliamentary inquiry has found.

Some individuals told MPs they received no scheduled follow-up after their diagnosis, while others faced years-long waits for crucial bone scans.

Further highlighting the systemic issues, a new report by the All-Party Parliamentary Group (APPG) on osteoporosis and bone health revealed that only 34% of eligible patients are receiving medication to prevent fractures.

Experts condemned the findings, stating they expose a "deep, structural failure in how the NHS treats a condition affecting millions", putting patients at risk of losing their independence and facing premature death.

The patient survey found that more than half had not been contacted by a healthcare professional about their condition in the past year, while almost one in four (23%) had not been contacted in more than three years.

Fewer than a third (30%) said they were satisfied with how their osteoporosis is monitored by the NHS.

These satisfaction levels differed in deprived areas (28%) compared to wealthier areas (50%).

Meanwhile, the research found that half of all integrated care boards (ICBs) and health boards have no defined osteoporosis care pathway connecting hospitals and primary care.

The APPG said a “particularly troubling” theme to emerge from the inquiry is the “sense of abandonment felt by many people with osteoporosis as a result of the lack of clinical ownership of their condition”.

Read full story

Source: The Independent, 22 January 2026

Read more

Orthopaedic patients face seven-year wait for surgery

Orthopaedic patients in NHS Highland face a wait of up to seven years for surgery, new research has found.

A University of Aberdeen study said the worst case estimate would apply if surgical rates did not increase for those listed in July this year.

Researchers also discovered the average wait across Scotland's 14 health boards could be as long as two years and three months.

The Scottish government said it was working to maximise NHS capacity.

Luke Farrow, clinical research fellow, warned that the significance of the delays could not be underestimated.

He said: "Prolonged waits for certain orthopaedic procedures can have a major negative impact on patient health.

"This occurs both in terms of deterioration in quality of life whilst awaiting surgery, as well as potential negative connotations for post-operative recovery and longer-term health in addition to reduced independence and increased social care needs."

Read full story

Source: BBC News, 14 December 2022

Read more

Orthodontist advised treatment with risk of harm to children, tribunal told

An orthodontist whose methods around shaping the jawline have gone viral advised treatment to young children that “carried a risk of harm”, a tribunal has heard. Dr Mike Mew, whose “mewing” techniques have racked up nearly 2 biillion views on TikTok, faces a misconduct hearing at the General Dental Council (GDC).

Opening the hearing in central London on Monday, Lydia Barnfather, representing the GDC, said comments made by Mew, who claims to help “alter the cranial facial structure” on his YouTube channel, were “pejorative” about orthodontists.

Barnfather told the professional conduct committee that Mew seeks to treat children with “head and neck gear” and “lower and upper arch expansion appliances” to help align teeth and shape the jawline.

“The GDC alleges this is not only very protracted, expensive, uncomfortable and highly demanding of the child, but it carries the risk of harm", Barnfather said.

It was heard that between September 2013 and May 2019, advice and treatment were provided to two children, referred to as Patient A and Patient B.

Mew was accused of failing to “carry out appropriate monitoring” of their treatment and “ought to have known” this was liable to cause harm.

Barnfather said: “The GDC allege you are not to have treated patients the way you did.”

She argued that both children had “perfectly normal cranial facial development for their age” before treatment took place. She added that the treatment was “not clinically indicated” and that Mew “had no adequate objective evidence” it would achieve its aims.

Read full story

Source: The Guardian, 14 November 2022

Read more

Organ transplants: Black people wait up to six months longer, NHS figures show

Black patients wait up to six months longer for an organ transplant than the general population, new NHS data shows.

The best match comes from someone of the same ethnicity - but only 2% of donors in 2021/22 were black, while black people are 4% of the population.

Black families are also less likely to agree to organ donation than white families, the figures show. The NHS says there's an "urgent need" for more people from ethnic minorities to donate.

Winnie Andango from NHS Blood and Transplant said, "Black people wait longer because there's less people coming forward to give their organs from their ethnic group. During covid, so many patients were suspended but those have been added back onto the list, and that means if we had less organs for this ethnic minority group, we have even less right now."

Health Minister Neil O'Brien said: "We need more people, especially those from black and Asian heritage, to register their organ donation decision and share it with their family so loved ones can follow their wishes."

Read full story

Source: BBC News, 12 January 2023

Read more

Organ harvesting: Trafficked for his kidney and now forced into hiding

Daniel was about to get the fright of his life.

He was sitting in a consulting room at the Royal Free hospital in London, speaking to doctors with his limited English.

The 21-year-old street trader from Lagos, Nigeria, had come to the UK days earlier for what he had been told was a "life-changing opportunity". He thought he was going to get a better job.

But now doctors were talking to him about the risks of the operation and the need for lifelong medical care.

It was at that moment, Daniel told investigators, that he realised there was no job opportunity and he had been brought to the UK to give a kidney to a stranger.

"He was going to literally be cut up like a piece of meat, take what they wanted out of him and then stitch him back up," according to Cristina Huddleston, from the anti modern slavery group Justice and Care.

Luckily for Daniel, the doctors had become suspicious that he didn't know what was going on and feared he was being coerced. So they halted the process.

 The BBC's File on 4 has learned that his ground-breaking case alerted UK authorities to other instances of organ trafficking. 

Read full story

Source: BBC News, 4 July 2023

Read more
 

Organ donation: Change to Northern Ireland law passes final hurdle

Campaigners have welcomed the "life-saving" legislation to bring opt-out organ donation to Northern Ireland.

The legislation, which will align Northern Ireland with the rest of the UK, passed its final stage in the assembly on Tuesday. It means people will automatically become donors unless they specifically state otherwise.

Máirtín MacGabhann, whose son Dáithí is waiting on a heart transplant, said it was "phenomenal".

The bill is to be known as 'Dáithí's Law' after the five-year-old whose family have campaigned for the law change.

Mr MacGabhann said it was an emotional day for them.

He told BBC NI's Evening Extra programme: "The most important thing, regardless of the name, is that it's passed its final stage and that life-saving legislation will go through."

Read full story

Source: BBC News, 9 February 2022

Read more
 

ORCHA launches COVID-19 Health App Formulary

Health apps have grown enormously in popularity, even more so during the COVID-19 Pandemic. Since early March, more than 500 health apps contain coronavirus-related keywords in their description.

People are taking advice from these apps, often using them to share sensitive information. Yet, in a time of fake reviews, scams and personal data breaches, not all health apps can be trusted. 

The Organisation for the Review of Care and Health Apps (ORCHA) has launched a health app formulary to help healthcare professionals and consumers know which health apps they can trust. 

As a free to use resource, the site includes reviews of health apps across a range of health conditions relevant to the COVID-19 pandemic, including reviews of COVID-19 apps launched to date.

Read full story

Source: ORCHA, 6 April 2020

Read more
 

Oral drug for spinal muscular atrophy to be available on NHS in England

The NHS is to introduce a revolutionary new treatment to tackle the leading genetic cause of death among babies and young children.

About 1,500 patients in England with certain types of spinal muscular atrophy (SMA) are expected to benefit from risdiplam, after a recommendation from the health watchdog. The drug, also called Evrysdi and made by Roche, is a syrup that can be taken at home and is the first non-injectable treatment for the condition.

SMA is a progressive neuromuscular condition affecting the nerves in the spinal cord controlling movement and can cause paralysis, muscle weakness and progressive loss of mobility.

The NHS England chief executive, Amanda Pritchard, said: “In the last three years the NHS has revolutionised care for people with SMA, by securing access to a trio of innovative treatments – Spinraza, Zolgensma and now risdiplam – where three years ago clinicians had no effective medicines at all.

“Spinal muscular atrophy is a cruel disease and the leading genetic cause of death among babies and young children, which is why NHS England has been determined to make these treatments available to people as soon as possible to help transform the lives of patients and their families.”

Meindert Boysen, the deputy chief executive of NICE, said the watchdog was pleased to recommend a “convenient oral treatment for people with SMA that can be administered at home”.

He said: “This will not only be less burdensome, and therefore have a positive impact on the lives of both people with SMA and their caregivers, but it will also reduce the treatment administration requirements for the NHS.

“In practical terms, the availability of an oral drug should lead to greater adherence to treatment, along with giving access to a treatment to those who aren’t able to have other currently recommended options.”

Read full story

Source: The Guardian, 19 November 2021

Read more
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.